What Is Going on With Invitae (NVTA) Stock Today?

66
6
Favorite

What Is Going on With Invitae (NVTA) Stock Today?

InvestorPlace2022-08-11

After soaring nearly 280% yesterday, Invitae(NVTA) stock is slumping today.The company reported stronger-than-expected Q2 results on Aug. 9.NVTA stock is being widely discussed on social media as a ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（6）

Gackky
·2022-08-12
what is going on with Tiger not letting me short NVT [Facepalm] [LOL] [Pitiful]
Reply
4
Report
Nikolos
·2022-08-11
Sell
Reply
1
Report
Nikolos
·2022-08-11
Sell
Reply
1
Report
Kiwii
·2022-08-11
halo
Reply
2
Report
Edwardtoh
·2022-08-11
Like
Reply
2
Report
Jennifer58
·2022-08-11
Buy
Reply
2
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1101027821?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-08-11 22:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1101027821","market":"us","top_or_hot":-1,"title":"What Is Going on With Invitae (NVTA) Stock Today?","media":"InvestorPlace","content":"<div>\n<p>After soaring nearly 280% yesterday, Invitae(NVTA) stock is slumping today.The company reported stronger-than-expected Q2 results on Aug. 9.NVTA stock is being widely discussed on social media as a ...</p>\n\n<a href=\"https://investorplace.com/2022/08/what-is-going-on-with-invitae-nvta-stock-today/\">Source Link</a>\n\n</div>\n","source":"lsy1606302653667","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What Is Going on With Invitae (NVTA) Stock Today?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat Is Going on With Invitae (NVTA) Stock Today?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-11 22:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/08/what-is-going-on-with-invitae-nvta-stock-today/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After soaring nearly 280% yesterday, Invitae(NVTA) stock is slumping today.The company reported stronger-than-expected Q2 results on Aug. 9.NVTA stock is being widely discussed on social media as a ...</p>\n\n<a href=\"https://investorplace.com/2022/08/what-is-going-on-with-invitae-nvta-stock-today/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NVTA","symbol_name":"Invitae Corporation","start_time":0,"source_url":"https://investorplace.com/2022/08/what-is-going-on-with-invitae-nvta-stock-today/","article_id":"1101027821","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1101027821","pubTimestamp":1660227599,"sourceInfo":{"source_id":"lsy1606302653667","name":"InvestorPlace"},"weMediaInfo":null,"summary":"After soaring nearly 280% yesterday, Invitae(NVTA) stock is slumping today.The company reported stro","collect":0,"end_time":0,"defaultTopTitle":"investorplace.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"NVTA":"Invitae Corporation"},"translate_title":"今天Invitae(NVTA)的股票是怎么回事？","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVTA":0.9},"content_text":"After soaring nearly 280% yesterday, Invitae(NVTA) stock is slumping today.The company reported stronger-than-expected Q2 results on Aug. 9.NVTA stock is being widely discussed on social media as a possible short squeeze target.After soaring 278% yesterday, Invitae(NYSE:NVTA) is falling over 40% in early trading today. NVTA stock might be undergoing a short squeeze.The company develops genetic tests that evaluate people’s risks of developing many diseases. The company’s tests cover a wide swath of different health conditions and healthcare fields “including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases.”Invitae’s Second-Quarter ResultsOn Aug. 9 after the market closed, Invitae announced that its revenue had climbed 17% year-over-year to $136.6 million, slightly above analysts’ average estimate of $136 million. It reported a per-share loss of 68 cents, versus analysts’ average estimate of a per-share loss of 76 cents.Invitae’s “total active healthcare provider accounts” climbed 25% YOY last quarter to 20,217, while its cash burn slowed to $147 million from $169 million in Q1 of 2022. The company expects to have enough cash to continue its operations until “the end of 2024.”On the guidance front, Invitae continues to anticipate that its revenue will increase around 10%-12% this year, and it still expects to burn $600 million to $650 million of cash this year. In 2023, Invitae continues to anticipate that its cash burn will fall from $275 million to $225 million.NVTA Stock: A Meme Stock in the Making?After releasing its Q2 results, Invitae garnered a significant amount of attention on social media. Many of those discussing NVTA stock on social media were urging retail investors to work together to create a “short squeeze” in the name.Driven by similar tactics, GameStop(NYSE:GME), AMC(NYSE:AMC), and other “meme stocks” rallied tremendously last year. Invitae could be undergoing a similar phenomenon now.A Negative Preannouncement and Other News in JulyOn July 21, Invitae unveiled Q2 sales that were below analysts’ average outlook. The company also announced that its COO would become CEO, and reported that it would undergo a restructuring process that’s expected to generate “$326M in annualized cost savings by 2023.”","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9907718589,"gmtCreate":1660258180645,"gmtModify":1676531760324,"author":{"id":"3574326723774097","authorId":"3574326723774097","name":"Gackky","avatar":"https://static.tigerbbs.com/5898b44bf5a31bf2b9d4e37227ed8177","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"what is going on with Tiger not letting me short NVT&nbsp;[Facepalm]&nbsp;[LOL]&nbsp;[Pitiful]&nbsp;","listText":"what is going on with Tiger not letting me short NVT&nbsp;[Facepalm]&nbsp;[LOL]&nbsp;[Pitiful]&nbsp;","text":"what is going on with Tiger not letting me short NVT [Facepalm] [LOL] [Pitiful]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9907718589","repostId":1101027821,"repostType":4,"repost":{"id":"1101027821","pubTimestamp":1660227599,"share":"https://www.laohu8.com/m/news/1101027821?lang=&edition=full","pubTime":"2022-08-11 22:19","market":"us","language":"en","title":"What Is Going on With Invitae (NVTA) Stock Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=1101027821","media":"InvestorPlace","summary":"After soaring nearly 280% yesterday, Invitae(NVTA) stock is slumping today.The company reported stro","content":"<html><head></head><body><ul><li>After soaring nearly 280% yesterday, <b>Invitae</b>(<b><u>NVTA</u></b>) stock is slumping today.</li><li>The company reported stronger-than-expected Q2 results on Aug. 9.</li><li>NVTA stock is being widely discussed on social media as a possible short squeeze target.</li></ul><p>After soaring 278% yesterday, <b>Invitae</b>(NYSE:<b><u>NVTA</u></b>) is falling over 40% in early trading today. NVTA stock might be undergoing a short squeeze.</p><p>The company develops genetic tests that evaluate people’s risks of developing many diseases. The company’s tests cover a wide swath of different health conditions and healthcare fields “including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases.”</p><p><b>Invitae’s Second-Quarter Results</b></p><p>On Aug. 9 after the market closed, Invitae announced that its revenue had climbed 17% year-over-year to $136.6 million, slightly above analysts’ average estimate of $136 million. It reported a per-share loss of 68 cents, versus analysts’ average estimate of a per-share loss of 76 cents.</p><p>Invitae’s “total active healthcare provider accounts” climbed 25% YOY last quarter to 20,217, while its cash burn slowed to $147 million from $169 million in Q1 of 2022. The company expects to have enough cash to continue its operations until “the end of 2024.”</p><p>On the guidance front, Invitae continues to anticipate that its revenue will increase around 10%-12% this year, and it still expects to burn $600 million to $650 million of cash this year. In 2023, Invitae continues to anticipate that its cash burn will fall from $275 million to $225 million.</p><p><b>NVTA Stock: A Meme Stock in the Making?</b></p><p>After releasing its Q2 results, Invitae garnered a significant amount of attention on social media. Many of those discussing NVTA stock on social media were urging retail investors to work together to create a “short squeeze” in the name.</p><p>Driven by similar tactics, <b>GameStop</b>(NYSE:<b><u>GME</u></b>), <b>AMC</b>(NYSE:<b><u>AMC</u></b>), and other “meme stocks” rallied tremendously last year. Invitae could be undergoing a similar phenomenon now.</p><p><b>A Negative Preannouncement and Other News in July</b></p><p>On July 21, Invitae unveiled Q2 sales that were below analysts’ average outlook. The company also announced that its COO would become CEO, and reported that it would undergo a restructuring process that’s expected to generate “$326M in annualized cost savings by 2023.”</p></body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What Is Going on With Invitae (NVTA) Stock Today?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat Is Going on With Invitae (NVTA) Stock Today?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-11 22:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/08/what-is-going-on-with-invitae-nvta-stock-today/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After soaring nearly 280% yesterday, Invitae(NVTA) stock is slumping today.The company reported stronger-than-expected Q2 results on Aug. 9.NVTA stock is being widely discussed on social media as a ...</p>\n\n<a href=\"https://investorplace.com/2022/08/what-is-going-on-with-invitae-nvta-stock-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVTA":"Invitae Corporation"},"source_url":"https://investorplace.com/2022/08/what-is-going-on-with-invitae-nvta-stock-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101027821","content_text":"After soaring nearly 280% yesterday, Invitae(NVTA) stock is slumping today.The company reported stronger-than-expected Q2 results on Aug. 9.NVTA stock is being widely discussed on social media as a possible short squeeze target.After soaring 278% yesterday, Invitae(NYSE:NVTA) is falling over 40% in early trading today. NVTA stock might be undergoing a short squeeze.The company develops genetic tests that evaluate people’s risks of developing many diseases. The company’s tests cover a wide swath of different health conditions and healthcare fields “including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases.”Invitae’s Second-Quarter ResultsOn Aug. 9 after the market closed, Invitae announced that its revenue had climbed 17% year-over-year to $136.6 million, slightly above analysts’ average estimate of $136 million. It reported a per-share loss of 68 cents, versus analysts’ average estimate of a per-share loss of 76 cents.Invitae’s “total active healthcare provider accounts” climbed 25% YOY last quarter to 20,217, while its cash burn slowed to $147 million from $169 million in Q1 of 2022. The company expects to have enough cash to continue its operations until “the end of 2024.”On the guidance front, Invitae continues to anticipate that its revenue will increase around 10%-12% this year, and it still expects to burn $600 million to $650 million of cash this year. In 2023, Invitae continues to anticipate that its cash burn will fall from $275 million to $225 million.NVTA Stock: A Meme Stock in the Making?After releasing its Q2 results, Invitae garnered a significant amount of attention on social media. Many of those discussing NVTA stock on social media were urging retail investors to work together to create a “short squeeze” in the name.Driven by similar tactics, GameStop(NYSE:GME), AMC(NYSE:AMC), and other “meme stocks” rallied tremendously last year. Invitae could be undergoing a similar phenomenon now.A Negative Preannouncement and Other News in JulyOn July 21, Invitae unveiled Q2 sales that were below analysts’ average outlook. The company also announced that its COO would become CEO, and reported that it would undergo a restructuring process that’s expected to generate “$326M in annualized cost savings by 2023.”","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9907435099,"gmtCreate":1660229832114,"gmtModify":1703500947114,"author":{"id":"3580431063306678","authorId":"3580431063306678","name":"Nikolos","avatar":"https://community-static.tradeup.com/news/f3223fa1172af2dddec5418a841626f9","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Sell","listText":"Sell","text":"Sell","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9907435099","repostId":1101027821,"repostType":4,"repost":{"id":"1101027821","pubTimestamp":1660227599,"share":"https://www.laohu8.com/m/news/1101027821?lang=&edition=full","pubTime":"2022-08-11 22:19","market":"us","language":"en","title":"What Is Going on With Invitae (NVTA) Stock Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=1101027821","media":"InvestorPlace","summary":"After soaring nearly 280% yesterday, Invitae(NVTA) stock is slumping today.The company reported stro","content":"<html><head></head><body><ul><li>After soaring nearly 280% yesterday, <b>Invitae</b>(<b><u>NVTA</u></b>) stock is slumping today.</li><li>The company reported stronger-than-expected Q2 results on Aug. 9.</li><li>NVTA stock is being widely discussed on social media as a possible short squeeze target.</li></ul><p>After soaring 278% yesterday, <b>Invitae</b>(NYSE:<b><u>NVTA</u></b>) is falling over 40% in early trading today. NVTA stock might be undergoing a short squeeze.</p><p>The company develops genetic tests that evaluate people’s risks of developing many diseases. The company’s tests cover a wide swath of different health conditions and healthcare fields “including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases.”</p><p><b>Invitae’s Second-Quarter Results</b></p><p>On Aug. 9 after the market closed, Invitae announced that its revenue had climbed 17% year-over-year to $136.6 million, slightly above analysts’ average estimate of $136 million. It reported a per-share loss of 68 cents, versus analysts’ average estimate of a per-share loss of 76 cents.</p><p>Invitae’s “total active healthcare provider accounts” climbed 25% YOY last quarter to 20,217, while its cash burn slowed to $147 million from $169 million in Q1 of 2022. The company expects to have enough cash to continue its operations until “the end of 2024.”</p><p>On the guidance front, Invitae continues to anticipate that its revenue will increase around 10%-12% this year, and it still expects to burn $600 million to $650 million of cash this year. In 2023, Invitae continues to anticipate that its cash burn will fall from $275 million to $225 million.</p><p><b>NVTA Stock: A Meme Stock in the Making?</b></p><p>After releasing its Q2 results, Invitae garnered a significant amount of attention on social media. Many of those discussing NVTA stock on social media were urging retail investors to work together to create a “short squeeze” in the name.</p><p>Driven by similar tactics, <b>GameStop</b>(NYSE:<b><u>GME</u></b>), <b>AMC</b>(NYSE:<b><u>AMC</u></b>), and other “meme stocks” rallied tremendously last year. Invitae could be undergoing a similar phenomenon now.</p><p><b>A Negative Preannouncement and Other News in July</b></p><p>On July 21, Invitae unveiled Q2 sales that were below analysts’ average outlook. The company also announced that its COO would become CEO, and reported that it would undergo a restructuring process that’s expected to generate “$326M in annualized cost savings by 2023.”</p></body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What Is Going on With Invitae (NVTA) Stock Today?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat Is Going on With Invitae (NVTA) Stock Today?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-11 22:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/08/what-is-going-on-with-invitae-nvta-stock-today/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After soaring nearly 280% yesterday, Invitae(NVTA) stock is slumping today.The company reported stronger-than-expected Q2 results on Aug. 9.NVTA stock is being widely discussed on social media as a ...</p>\n\n<a href=\"https://investorplace.com/2022/08/what-is-going-on-with-invitae-nvta-stock-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVTA":"Invitae Corporation"},"source_url":"https://investorplace.com/2022/08/what-is-going-on-with-invitae-nvta-stock-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101027821","content_text":"After soaring nearly 280% yesterday, Invitae(NVTA) stock is slumping today.The company reported stronger-than-expected Q2 results on Aug. 9.NVTA stock is being widely discussed on social media as a possible short squeeze target.After soaring 278% yesterday, Invitae(NYSE:NVTA) is falling over 40% in early trading today. NVTA stock might be undergoing a short squeeze.The company develops genetic tests that evaluate people’s risks of developing many diseases. The company’s tests cover a wide swath of different health conditions and healthcare fields “including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases.”Invitae’s Second-Quarter ResultsOn Aug. 9 after the market closed, Invitae announced that its revenue had climbed 17% year-over-year to $136.6 million, slightly above analysts’ average estimate of $136 million. It reported a per-share loss of 68 cents, versus analysts’ average estimate of a per-share loss of 76 cents.Invitae’s “total active healthcare provider accounts” climbed 25% YOY last quarter to 20,217, while its cash burn slowed to $147 million from $169 million in Q1 of 2022. The company expects to have enough cash to continue its operations until “the end of 2024.”On the guidance front, Invitae continues to anticipate that its revenue will increase around 10%-12% this year, and it still expects to burn $600 million to $650 million of cash this year. In 2023, Invitae continues to anticipate that its cash burn will fall from $275 million to $225 million.NVTA Stock: A Meme Stock in the Making?After releasing its Q2 results, Invitae garnered a significant amount of attention on social media. Many of those discussing NVTA stock on social media were urging retail investors to work together to create a “short squeeze” in the name.Driven by similar tactics, GameStop(NYSE:GME), AMC(NYSE:AMC), and other “meme stocks” rallied tremendously last year. Invitae could be undergoing a similar phenomenon now.A Negative Preannouncement and Other News in JulyOn July 21, Invitae unveiled Q2 sales that were below analysts’ average outlook. The company also announced that its COO would become CEO, and reported that it would undergo a restructuring process that’s expected to generate “$326M in annualized cost savings by 2023.”","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9907432494,"gmtCreate":1660229798119,"gmtModify":1703500862892,"author":{"id":"3580431063306678","authorId":"3580431063306678","name":"Nikolos","avatar":"https://community-static.tradeup.com/news/f3223fa1172af2dddec5418a841626f9","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Sell","listText":"Sell","text":"Sell","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9907432494","repostId":1101027821,"repostType":4,"repost":{"id":"1101027821","pubTimestamp":1660227599,"share":"https://www.laohu8.com/m/news/1101027821?lang=&edition=full","pubTime":"2022-08-11 22:19","market":"us","language":"en","title":"What Is Going on With Invitae (NVTA) Stock Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=1101027821","media":"InvestorPlace","summary":"After soaring nearly 280% yesterday, Invitae(NVTA) stock is slumping today.The company reported stro","content":"<html><head></head><body><ul><li>After soaring nearly 280% yesterday, <b>Invitae</b>(<b><u>NVTA</u></b>) stock is slumping today.</li><li>The company reported stronger-than-expected Q2 results on Aug. 9.</li><li>NVTA stock is being widely discussed on social media as a possible short squeeze target.</li></ul><p>After soaring 278% yesterday, <b>Invitae</b>(NYSE:<b><u>NVTA</u></b>) is falling over 40% in early trading today. NVTA stock might be undergoing a short squeeze.</p><p>The company develops genetic tests that evaluate people’s risks of developing many diseases. The company’s tests cover a wide swath of different health conditions and healthcare fields “including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases.”</p><p><b>Invitae’s Second-Quarter Results</b></p><p>On Aug. 9 after the market closed, Invitae announced that its revenue had climbed 17% year-over-year to $136.6 million, slightly above analysts’ average estimate of $136 million. It reported a per-share loss of 68 cents, versus analysts’ average estimate of a per-share loss of 76 cents.</p><p>Invitae’s “total active healthcare provider accounts” climbed 25% YOY last quarter to 20,217, while its cash burn slowed to $147 million from $169 million in Q1 of 2022. The company expects to have enough cash to continue its operations until “the end of 2024.”</p><p>On the guidance front, Invitae continues to anticipate that its revenue will increase around 10%-12% this year, and it still expects to burn $600 million to $650 million of cash this year. In 2023, Invitae continues to anticipate that its cash burn will fall from $275 million to $225 million.</p><p><b>NVTA Stock: A Meme Stock in the Making?</b></p><p>After releasing its Q2 results, Invitae garnered a significant amount of attention on social media. Many of those discussing NVTA stock on social media were urging retail investors to work together to create a “short squeeze” in the name.</p><p>Driven by similar tactics, <b>GameStop</b>(NYSE:<b><u>GME</u></b>), <b>AMC</b>(NYSE:<b><u>AMC</u></b>), and other “meme stocks” rallied tremendously last year. Invitae could be undergoing a similar phenomenon now.</p><p><b>A Negative Preannouncement and Other News in July</b></p><p>On July 21, Invitae unveiled Q2 sales that were below analysts’ average outlook. The company also announced that its COO would become CEO, and reported that it would undergo a restructuring process that’s expected to generate “$326M in annualized cost savings by 2023.”</p></body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What Is Going on With Invitae (NVTA) Stock Today?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat Is Going on With Invitae (NVTA) Stock Today?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-11 22:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/08/what-is-going-on-with-invitae-nvta-stock-today/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After soaring nearly 280% yesterday, Invitae(NVTA) stock is slumping today.The company reported stronger-than-expected Q2 results on Aug. 9.NVTA stock is being widely discussed on social media as a ...</p>\n\n<a href=\"https://investorplace.com/2022/08/what-is-going-on-with-invitae-nvta-stock-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVTA":"Invitae Corporation"},"source_url":"https://investorplace.com/2022/08/what-is-going-on-with-invitae-nvta-stock-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101027821","content_text":"After soaring nearly 280% yesterday, Invitae(NVTA) stock is slumping today.The company reported stronger-than-expected Q2 results on Aug. 9.NVTA stock is being widely discussed on social media as a possible short squeeze target.After soaring 278% yesterday, Invitae(NYSE:NVTA) is falling over 40% in early trading today. NVTA stock might be undergoing a short squeeze.The company develops genetic tests that evaluate people’s risks of developing many diseases. The company’s tests cover a wide swath of different health conditions and healthcare fields “including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases.”Invitae’s Second-Quarter ResultsOn Aug. 9 after the market closed, Invitae announced that its revenue had climbed 17% year-over-year to $136.6 million, slightly above analysts’ average estimate of $136 million. It reported a per-share loss of 68 cents, versus analysts’ average estimate of a per-share loss of 76 cents.Invitae’s “total active healthcare provider accounts” climbed 25% YOY last quarter to 20,217, while its cash burn slowed to $147 million from $169 million in Q1 of 2022. The company expects to have enough cash to continue its operations until “the end of 2024.”On the guidance front, Invitae continues to anticipate that its revenue will increase around 10%-12% this year, and it still expects to burn $600 million to $650 million of cash this year. In 2023, Invitae continues to anticipate that its cash burn will fall from $275 million to $225 million.NVTA Stock: A Meme Stock in the Making?After releasing its Q2 results, Invitae garnered a significant amount of attention on social media. Many of those discussing NVTA stock on social media were urging retail investors to work together to create a “short squeeze” in the name.Driven by similar tactics, GameStop(NYSE:GME), AMC(NYSE:AMC), and other “meme stocks” rallied tremendously last year. Invitae could be undergoing a similar phenomenon now.A Negative Preannouncement and Other News in JulyOn July 21, Invitae unveiled Q2 sales that were below analysts’ average outlook. The company also announced that its COO would become CEO, and reported that it would undergo a restructuring process that’s expected to generate “$326M in annualized cost savings by 2023.”","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9907497588,"gmtCreate":1660229082346,"gmtModify":1703498148105,"author":{"id":"3579735899676546","authorId":"3579735899676546","name":"Kiwii","avatar":"https://community-static.tradeup.com/news/c31b2d8301c0e367c9f368c3506dad90","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"halo","listText":"halo","text":"halo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9907497588","repostId":1101027821,"repostType":4,"repost":{"id":"1101027821","pubTimestamp":1660227599,"share":"https://www.laohu8.com/m/news/1101027821?lang=&edition=full","pubTime":"2022-08-11 22:19","market":"us","language":"en","title":"What Is Going on With Invitae (NVTA) Stock Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=1101027821","media":"InvestorPlace","summary":"After soaring nearly 280% yesterday, Invitae(NVTA) stock is slumping today.The company reported stro","content":"<html><head></head><body><ul><li>After soaring nearly 280% yesterday, <b>Invitae</b>(<b><u>NVTA</u></b>) stock is slumping today.</li><li>The company reported stronger-than-expected Q2 results on Aug. 9.</li><li>NVTA stock is being widely discussed on social media as a possible short squeeze target.</li></ul><p>After soaring 278% yesterday, <b>Invitae</b>(NYSE:<b><u>NVTA</u></b>) is falling over 40% in early trading today. NVTA stock might be undergoing a short squeeze.</p><p>The company develops genetic tests that evaluate people’s risks of developing many diseases. The company’s tests cover a wide swath of different health conditions and healthcare fields “including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases.”</p><p><b>Invitae’s Second-Quarter Results</b></p><p>On Aug. 9 after the market closed, Invitae announced that its revenue had climbed 17% year-over-year to $136.6 million, slightly above analysts’ average estimate of $136 million. It reported a per-share loss of 68 cents, versus analysts’ average estimate of a per-share loss of 76 cents.</p><p>Invitae’s “total active healthcare provider accounts” climbed 25% YOY last quarter to 20,217, while its cash burn slowed to $147 million from $169 million in Q1 of 2022. The company expects to have enough cash to continue its operations until “the end of 2024.”</p><p>On the guidance front, Invitae continues to anticipate that its revenue will increase around 10%-12% this year, and it still expects to burn $600 million to $650 million of cash this year. In 2023, Invitae continues to anticipate that its cash burn will fall from $275 million to $225 million.</p><p><b>NVTA Stock: A Meme Stock in the Making?</b></p><p>After releasing its Q2 results, Invitae garnered a significant amount of attention on social media. Many of those discussing NVTA stock on social media were urging retail investors to work together to create a “short squeeze” in the name.</p><p>Driven by similar tactics, <b>GameStop</b>(NYSE:<b><u>GME</u></b>), <b>AMC</b>(NYSE:<b><u>AMC</u></b>), and other “meme stocks” rallied tremendously last year. Invitae could be undergoing a similar phenomenon now.</p><p><b>A Negative Preannouncement and Other News in July</b></p><p>On July 21, Invitae unveiled Q2 sales that were below analysts’ average outlook. The company also announced that its COO would become CEO, and reported that it would undergo a restructuring process that’s expected to generate “$326M in annualized cost savings by 2023.”</p></body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What Is Going on With Invitae (NVTA) Stock Today?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat Is Going on With Invitae (NVTA) Stock Today?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-11 22:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/08/what-is-going-on-with-invitae-nvta-stock-today/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After soaring nearly 280% yesterday, Invitae(NVTA) stock is slumping today.The company reported stronger-than-expected Q2 results on Aug. 9.NVTA stock is being widely discussed on social media as a ...</p>\n\n<a href=\"https://investorplace.com/2022/08/what-is-going-on-with-invitae-nvta-stock-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVTA":"Invitae Corporation"},"source_url":"https://investorplace.com/2022/08/what-is-going-on-with-invitae-nvta-stock-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101027821","content_text":"After soaring nearly 280% yesterday, Invitae(NVTA) stock is slumping today.The company reported stronger-than-expected Q2 results on Aug. 9.NVTA stock is being widely discussed on social media as a possible short squeeze target.After soaring 278% yesterday, Invitae(NYSE:NVTA) is falling over 40% in early trading today. NVTA stock might be undergoing a short squeeze.The company develops genetic tests that evaluate people’s risks of developing many diseases. The company’s tests cover a wide swath of different health conditions and healthcare fields “including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases.”Invitae’s Second-Quarter ResultsOn Aug. 9 after the market closed, Invitae announced that its revenue had climbed 17% year-over-year to $136.6 million, slightly above analysts’ average estimate of $136 million. It reported a per-share loss of 68 cents, versus analysts’ average estimate of a per-share loss of 76 cents.Invitae’s “total active healthcare provider accounts” climbed 25% YOY last quarter to 20,217, while its cash burn slowed to $147 million from $169 million in Q1 of 2022. The company expects to have enough cash to continue its operations until “the end of 2024.”On the guidance front, Invitae continues to anticipate that its revenue will increase around 10%-12% this year, and it still expects to burn $600 million to $650 million of cash this year. In 2023, Invitae continues to anticipate that its cash burn will fall from $275 million to $225 million.NVTA Stock: A Meme Stock in the Making?After releasing its Q2 results, Invitae garnered a significant amount of attention on social media. Many of those discussing NVTA stock on social media were urging retail investors to work together to create a “short squeeze” in the name.Driven by similar tactics, GameStop(NYSE:GME), AMC(NYSE:AMC), and other “meme stocks” rallied tremendously last year. Invitae could be undergoing a similar phenomenon now.A Negative Preannouncement and Other News in JulyOn July 21, Invitae unveiled Q2 sales that were below analysts’ average outlook. The company also announced that its COO would become CEO, and reported that it would undergo a restructuring process that’s expected to generate “$326M in annualized cost savings by 2023.”","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9907494427,"gmtCreate":1660228953071,"gmtModify":1703497803334,"author":{"id":"3586301355400538","authorId":"3586301355400538","name":"Edwardtoh","avatar":"https://static.tigerbbs.com/b46042c9b9b5dcea7d55f33bccb139cc","vip":1,"crmLevel":2,"crmLevelSwitch":1},"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9907494427","repostId":1101027821,"repostType":4,"repost":{"id":"1101027821","pubTimestamp":1660227599,"share":"https://www.laohu8.com/m/news/1101027821?lang=&edition=full","pubTime":"2022-08-11 22:19","market":"us","language":"en","title":"What Is Going on With Invitae (NVTA) Stock Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=1101027821","media":"InvestorPlace","summary":"After soaring nearly 280% yesterday, Invitae(NVTA) stock is slumping today.The company reported stro","content":"<html><head></head><body><ul><li>After soaring nearly 280% yesterday, <b>Invitae</b>(<b><u>NVTA</u></b>) stock is slumping today.</li><li>The company reported stronger-than-expected Q2 results on Aug. 9.</li><li>NVTA stock is being widely discussed on social media as a possible short squeeze target.</li></ul><p>After soaring 278% yesterday, <b>Invitae</b>(NYSE:<b><u>NVTA</u></b>) is falling over 40% in early trading today. NVTA stock might be undergoing a short squeeze.</p><p>The company develops genetic tests that evaluate people’s risks of developing many diseases. The company’s tests cover a wide swath of different health conditions and healthcare fields “including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases.”</p><p><b>Invitae’s Second-Quarter Results</b></p><p>On Aug. 9 after the market closed, Invitae announced that its revenue had climbed 17% year-over-year to $136.6 million, slightly above analysts’ average estimate of $136 million. It reported a per-share loss of 68 cents, versus analysts’ average estimate of a per-share loss of 76 cents.</p><p>Invitae’s “total active healthcare provider accounts” climbed 25% YOY last quarter to 20,217, while its cash burn slowed to $147 million from $169 million in Q1 of 2022. The company expects to have enough cash to continue its operations until “the end of 2024.”</p><p>On the guidance front, Invitae continues to anticipate that its revenue will increase around 10%-12% this year, and it still expects to burn $600 million to $650 million of cash this year. In 2023, Invitae continues to anticipate that its cash burn will fall from $275 million to $225 million.</p><p><b>NVTA Stock: A Meme Stock in the Making?</b></p><p>After releasing its Q2 results, Invitae garnered a significant amount of attention on social media. Many of those discussing NVTA stock on social media were urging retail investors to work together to create a “short squeeze” in the name.</p><p>Driven by similar tactics, <b>GameStop</b>(NYSE:<b><u>GME</u></b>), <b>AMC</b>(NYSE:<b><u>AMC</u></b>), and other “meme stocks” rallied tremendously last year. Invitae could be undergoing a similar phenomenon now.</p><p><b>A Negative Preannouncement and Other News in July</b></p><p>On July 21, Invitae unveiled Q2 sales that were below analysts’ average outlook. The company also announced that its COO would become CEO, and reported that it would undergo a restructuring process that’s expected to generate “$326M in annualized cost savings by 2023.”</p></body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What Is Going on With Invitae (NVTA) Stock Today?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat Is Going on With Invitae (NVTA) Stock Today?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-11 22:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/08/what-is-going-on-with-invitae-nvta-stock-today/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After soaring nearly 280% yesterday, Invitae(NVTA) stock is slumping today.The company reported stronger-than-expected Q2 results on Aug. 9.NVTA stock is being widely discussed on social media as a ...</p>\n\n<a href=\"https://investorplace.com/2022/08/what-is-going-on-with-invitae-nvta-stock-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVTA":"Invitae Corporation"},"source_url":"https://investorplace.com/2022/08/what-is-going-on-with-invitae-nvta-stock-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101027821","content_text":"After soaring nearly 280% yesterday, Invitae(NVTA) stock is slumping today.The company reported stronger-than-expected Q2 results on Aug. 9.NVTA stock is being widely discussed on social media as a possible short squeeze target.After soaring 278% yesterday, Invitae(NYSE:NVTA) is falling over 40% in early trading today. NVTA stock might be undergoing a short squeeze.The company develops genetic tests that evaluate people’s risks of developing many diseases. The company’s tests cover a wide swath of different health conditions and healthcare fields “including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases.”Invitae’s Second-Quarter ResultsOn Aug. 9 after the market closed, Invitae announced that its revenue had climbed 17% year-over-year to $136.6 million, slightly above analysts’ average estimate of $136 million. It reported a per-share loss of 68 cents, versus analysts’ average estimate of a per-share loss of 76 cents.Invitae’s “total active healthcare provider accounts” climbed 25% YOY last quarter to 20,217, while its cash burn slowed to $147 million from $169 million in Q1 of 2022. The company expects to have enough cash to continue its operations until “the end of 2024.”On the guidance front, Invitae continues to anticipate that its revenue will increase around 10%-12% this year, and it still expects to burn $600 million to $650 million of cash this year. In 2023, Invitae continues to anticipate that its cash burn will fall from $275 million to $225 million.NVTA Stock: A Meme Stock in the Making?After releasing its Q2 results, Invitae garnered a significant amount of attention on social media. Many of those discussing NVTA stock on social media were urging retail investors to work together to create a “short squeeze” in the name.Driven by similar tactics, GameStop(NYSE:GME), AMC(NYSE:AMC), and other “meme stocks” rallied tremendously last year. Invitae could be undergoing a similar phenomenon now.A Negative Preannouncement and Other News in JulyOn July 21, Invitae unveiled Q2 sales that were below analysts’ average outlook. The company also announced that its COO would become CEO, and reported that it would undergo a restructuring process that’s expected to generate “$326M in annualized cost savings by 2023.”","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9907495368,"gmtCreate":1660228674856,"gmtModify":1703497090879,"author":{"id":"3577529300728738","authorId":"3577529300728738","name":"Jennifer58","avatar":"https://static.tigerbbs.com/9a014efda004b6cc112e5d7968adf52f","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"Buy","listText":"Buy","text":"Buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9907495368","repostId":1101027821,"repostType":4,"repost":{"id":"1101027821","pubTimestamp":1660227599,"share":"https://www.laohu8.com/m/news/1101027821?lang=&edition=full","pubTime":"2022-08-11 22:19","market":"us","language":"en","title":"What Is Going on With Invitae (NVTA) Stock Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=1101027821","media":"InvestorPlace","summary":"After soaring nearly 280% yesterday, Invitae(NVTA) stock is slumping today.The company reported stro","content":"<html><head></head><body><ul><li>After soaring nearly 280% yesterday, <b>Invitae</b>(<b><u>NVTA</u></b>) stock is slumping today.</li><li>The company reported stronger-than-expected Q2 results on Aug. 9.</li><li>NVTA stock is being widely discussed on social media as a possible short squeeze target.</li></ul><p>After soaring 278% yesterday, <b>Invitae</b>(NYSE:<b><u>NVTA</u></b>) is falling over 40% in early trading today. NVTA stock might be undergoing a short squeeze.</p><p>The company develops genetic tests that evaluate people’s risks of developing many diseases. The company’s tests cover a wide swath of different health conditions and healthcare fields “including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases.”</p><p><b>Invitae’s Second-Quarter Results</b></p><p>On Aug. 9 after the market closed, Invitae announced that its revenue had climbed 17% year-over-year to $136.6 million, slightly above analysts’ average estimate of $136 million. It reported a per-share loss of 68 cents, versus analysts’ average estimate of a per-share loss of 76 cents.</p><p>Invitae’s “total active healthcare provider accounts” climbed 25% YOY last quarter to 20,217, while its cash burn slowed to $147 million from $169 million in Q1 of 2022. The company expects to have enough cash to continue its operations until “the end of 2024.”</p><p>On the guidance front, Invitae continues to anticipate that its revenue will increase around 10%-12% this year, and it still expects to burn $600 million to $650 million of cash this year. In 2023, Invitae continues to anticipate that its cash burn will fall from $275 million to $225 million.</p><p><b>NVTA Stock: A Meme Stock in the Making?</b></p><p>After releasing its Q2 results, Invitae garnered a significant amount of attention on social media. Many of those discussing NVTA stock on social media were urging retail investors to work together to create a “short squeeze” in the name.</p><p>Driven by similar tactics, <b>GameStop</b>(NYSE:<b><u>GME</u></b>), <b>AMC</b>(NYSE:<b><u>AMC</u></b>), and other “meme stocks” rallied tremendously last year. Invitae could be undergoing a similar phenomenon now.</p><p><b>A Negative Preannouncement and Other News in July</b></p><p>On July 21, Invitae unveiled Q2 sales that were below analysts’ average outlook. The company also announced that its COO would become CEO, and reported that it would undergo a restructuring process that’s expected to generate “$326M in annualized cost savings by 2023.”</p></body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What Is Going on With Invitae (NVTA) Stock Today?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat Is Going on With Invitae (NVTA) Stock Today?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-11 22:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/08/what-is-going-on-with-invitae-nvta-stock-today/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After soaring nearly 280% yesterday, Invitae(NVTA) stock is slumping today.The company reported stronger-than-expected Q2 results on Aug. 9.NVTA stock is being widely discussed on social media as a ...</p>\n\n<a href=\"https://investorplace.com/2022/08/what-is-going-on-with-invitae-nvta-stock-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVTA":"Invitae Corporation"},"source_url":"https://investorplace.com/2022/08/what-is-going-on-with-invitae-nvta-stock-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101027821","content_text":"After soaring nearly 280% yesterday, Invitae(NVTA) stock is slumping today.The company reported stronger-than-expected Q2 results on Aug. 9.NVTA stock is being widely discussed on social media as a possible short squeeze target.After soaring 278% yesterday, Invitae(NYSE:NVTA) is falling over 40% in early trading today. NVTA stock might be undergoing a short squeeze.The company develops genetic tests that evaluate people’s risks of developing many diseases. The company’s tests cover a wide swath of different health conditions and healthcare fields “including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases.”Invitae’s Second-Quarter ResultsOn Aug. 9 after the market closed, Invitae announced that its revenue had climbed 17% year-over-year to $136.6 million, slightly above analysts’ average estimate of $136 million. It reported a per-share loss of 68 cents, versus analysts’ average estimate of a per-share loss of 76 cents.Invitae’s “total active healthcare provider accounts” climbed 25% YOY last quarter to 20,217, while its cash burn slowed to $147 million from $169 million in Q1 of 2022. The company expects to have enough cash to continue its operations until “the end of 2024.”On the guidance front, Invitae continues to anticipate that its revenue will increase around 10%-12% this year, and it still expects to burn $600 million to $650 million of cash this year. In 2023, Invitae continues to anticipate that its cash burn will fall from $275 million to $225 million.NVTA Stock: A Meme Stock in the Making?After releasing its Q2 results, Invitae garnered a significant amount of attention on social media. Many of those discussing NVTA stock on social media were urging retail investors to work together to create a “short squeeze” in the name.Driven by similar tactics, GameStop(NYSE:GME), AMC(NYSE:AMC), and other “meme stocks” rallied tremendously last year. Invitae could be undergoing a similar phenomenon now.A Negative Preannouncement and Other News in JulyOn July 21, Invitae unveiled Q2 sales that were below analysts’ average outlook. The company also announced that its COO would become CEO, and reported that it would undergo a restructuring process that’s expected to generate “$326M in annualized cost savings by 2023.”","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":66,"commentSize":6,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}